Table 1 Fatty Acid Composition of HUVECs treated by 9t18:1 and 11t18:1(mg/g total fat).

From: 9c11tCLA modulates 11t18:1 and 9t18:1 induced inflammations differently in human umbilical vein endothelial cells

Fatty acids in lipid fractions

control

leptin

11t18:1(100 μmol/L) + Leptin (75 nmol/L)

11t18:1/(μmol/L)

9t18:1/(μmol/L)

25

50

100

25

50

100

SFA

289.44 ± 3.28ab

49.68 ± 0.96a

200.56 ± 2.72c

280.08 ± 4.16ab

268.48 ± 6.40b

205.44 ± 1.76c

290.00 ± 14.24a

246.72 ± 16.08b

173.60 ± 10.08d

ΣcisMUFA

406.32 ± 3.12a

416.08 ± 1.44a

302.96 ± 2.40c

351.44 ± 2.72b

305.68 ± 8.80c

292.72 ± 3.36d

360.56 ± 6.56b

349.76 ± 9.68b

339.76 ± 14.08b

ΣPUFA

91.28 ± 2.88a

86.48 ± 0.56a

29.20 ± 0.96c

72.56 ± 2.48ab

64.88 ± 11.84b

62.64 ± 0.96b

61.36 ± 7.36b

56.72 ± 4.48b

47.20 ± 4.16bc

ΣTFA

12.96 ± 0.16e

7.76 ± 0.80e

267.28 ± 1.60a

95.92 ± 2.40d

160.96 ± 1.36c

239.20 ± 0.48b

88.08 ± 3.04d

146.80 ± 3.68c

239.44 ± 11.28b

ΣCLA

1.36 ± 0.08d

0.96 ± 0.40d

39.52 ± 1.04bc

26.16 ± 2.08c

40.48 ± 0.24b

79.52 ± 1.04a

1.68 ± 0.48d

1.12 ± 0.72d

2.64 ± 1.20d

9t18:1

3.68 ± 0.80d

4.00 ± 0.16d

3.92 ± 0.08d

3.76 ± 0.80d

3.92 ± 0.80 d

2.40 ± 1.04d

80.48 ± 7.04c

137.68 ± 12.24b

270.88 ± 9.68a

11t18:1

1.92 ± 0.08e

2.88 ± 0.80e

277.12 ± 0.32a

73.36 ± 5.68d

120.16 ± 2.48c

241.52 ± 0.24b

1.52 ± 0.80e

0.64 ± 0.16e

1.04 ± 0.56e

9c11t-CLA

0.56 ± 0.00d

ND

36.32 ± 0.80b

23.28 ± 2.16c

35.44 ± 0.80b

70.08 ± 1.84a

0.56 ± 0.80d

1.12 ± 0.64d

0.56 ± 0.96d

  1. aMean values ± SD (n = 3). Values in the same row with different letters for each species show significant differences (p < 0.05). ΣSFA, total saturated fatty acids, Σcis MUFA, total cis monounsaturated fatty acids, ΣTFA, total trans fatty acids, ΣPUFA, total polyunsaturated fatty acids, ΣCLA, total conjugated linoleic acid.